Compounds > tryptophan

tryptophan and B16 Melanoma

tryptophan has been researched along with B16 Melanoma in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's3 (27.27)24.3611
2020's5 (45.45)2.80

Authors

AuthorsStudies
Belladonna, ML; Bicciato, S; Fallarino, F; Gargaro, M; Macchiarulo, A; Mondanelli, G; Orabona, C; Orecchini, E; Pallotta, MT; Panfili, E; Rossini, S; Suvieri, C; Volpi, C; Zizi, L1
Firat, E; Gaedicke, S; Guffart, E; Niedermann, G; Watanabe, T1
Gao, S; Hu, Z; Lu, W; Xu, J; Zheng, B1
Buijsman, RC; de Man, J; de Wit, J; den Ouden, JE; Grobben, Y; Massuger, LF; Mulder, WR; Muller, M; Prinsen, MBW; Sterrenburg, JG; Uitdehaag, JCM; van Altena, AM; van Cauter, F; van Doornmalen, AM; Vu-Pham, D; Willemsen-Seegers, N; Zaman, GJR1
Huang, P; Liu, J; Song, H; Su, Q; Wang, C; Wang, W; Zhang, C; Zhang, J; Zhang, Y1
Du, G; Liu, Q; Meng, X; Sun, S; Tian, J; Wang, H; Wang, W; Wu, Z; Ye, L1
Feng, Y; Feng, Z; Guo, J; Guo, M; Jia, H; Ren, W; Song, X; Tian, Z; Wang, H; Wang, M; Wei, T; Zhao, J; Zhao, T1
Bellone, M; Colombo, B; Corti, A; Curnis, F; Gasparri, AM; Jachetti, E; Rizzardi, GP; Sacchi, A; Traversari, C1
Baban, B; Blazar, BR; Chandler, PR; He, Y; Hou, DY; Koni, PA; Mellor, AL; Munn, DH; Sharma, MD1
Dyall, R; Engelhorn, ME; Ferrone, CR; Gold, JS; Guevara-Patiño, JA; Hawkins, WG; Houghton, AN; Lewis, JJ; Wolchok, JD1
Banerjee, T; DuHadaway, J; Hou, DY; Johnson, M; Mellor, AL; Muller, AJ; Munn, DH; Prendergast, GC; Sharma, MD1

Other Studies

11 other study(ies) available for tryptophan and B16 Melanoma

ArticleYear
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma.
    Oncoimmunology, 2023, Volume: 12, Issue:1

    Topics: Animals; CD8-Positive T-Lymphocytes; Humans; Immune Checkpoint Proteins; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Signal Transduction; Tryptophan

2023
Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 02-15, Volume: 26, Issue:4

    Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chemoradiotherapy; Female; Killer Cells, Natural; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Programmed Cell Death 1 Receptor; Radiation Dose Hypofractionation; Survival Rate; Tryptophan

2020
An albumin-bound drug conjugate of paclitaxel and indoleamine-2,3-dioxygenase inhibitor for enhanced cancer chemo-immunotherapy.
    Nanotechnology, 2020, May-01, Volume: 31, Issue:29

    Topics: Albumins; Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Drug Compounding; Drug Synergism; Female; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size; T-Lymphocytes, Regulatory; Treatment Outcome; Tryptophan; Xenograft Model Antitumor Assays

2020
Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Melanoma, Experimental; Mice; Small Molecule Libraries; Tryptophan

2020
Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy.
    Journal of materials chemistry. B, 2021, 05-12, Volume: 9, Issue:18

    Topics: Animals; Anions; Cancer Vaccines; Cations; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; CpG Islands; Dendritic Cells; Epitopes; Immunotherapy; Lipids; Liposomes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanostructures; Polymers; Survival Rate; Tryptophan

2021
Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.
    International journal of immunopathology and pharmacology, 2017, Volume: 30, Issue:3

    Topics: Animals; Antineoplastic Agents; Drug Therapy, Combination; Imidazoles; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Interleukin-2; Isoindoles; Kynurenine; Male; Melanoma, Experimental; Mice, Inbred C57BL; Paclitaxel; T-Lymphocytes; Tryptophan; Tumor Burden

2017
The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma.
    International journal of oncology, 2018, Volume: 53, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Evaluation, Preclinical; Drug Synergism; Humans; Immune Tolerance; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Pimozide; Skin Neoplasms; Tryptophan; Xenograft Model Antitumor Assays

2018
Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:12

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasms; Recombinant Fusion Proteins; Tryptophan

2008
Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice.
    Immunity, 2010, Dec-14, Volume: 33, Issue:6

    Topics: Adoptive Transfer; Animals; Antigens; CD8-Positive T-Lymphocytes; Cell Transdifferentiation; Cells, Cultured; Cross-Priming; Forkhead Transcription Factors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymphocyte Activation; Melanoma, Experimental; Mice; Mice, Inbred Strains; Oligodeoxyribonucleotides; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Toll-Like Receptor 9; Tryptophan

2010
A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen.
    Journal of immunology (Baltimore, Md. : 1950), 2003, May-15, Volume: 170, Issue:10

    Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Antigens, Heterophile; Asparagine; Cancer Vaccines; CD4-Positive T-Lymphocytes; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Epitopes, T-Lymphocyte; Female; Genes, Neoplasm; gp100 Melanoma Antigen; H-2 Antigens; Histocompatibility Antigen H-2D; Humans; Injections, Intraperitoneal; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Neoplasm Proteins; Peptide Fragments; Protein Binding; Tryptophan; Tumor Cells, Cultured; Vaccines, DNA

2003
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.
    Cancer research, 2007, Jan-15, Volume: 67, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dendritic Cells; Drug Synergism; Female; HeLa Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Paclitaxel; Stereoisomerism; Tryptophan

2007